Paratek Pharmaceuticals
PRTK
#9541
Rank
โ‚น12.13 B
Marketcap
โ‚น211.74
Share price
0.00%
Change (1 day)
23.66%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -โ‚น3.58 Billion

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.16 Billion. In 2022 the company made an earning of -โ‚น4.31 Billion a decrease over its 2021 earnings that were of -โ‚น3.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚น3.58 Billion-16.96%
2022 -โ‚น4.31 Billion10.5%
2021 -โ‚น3.91 Billion-46.16%
2020 -โ‚น7.25 Billion-31.93%
2019 -โ‚น10.65 Billion11.12%
2018 -โ‚น9.58 Billion21.19%
2017 -โ‚น7.91 Billion-23.22%
2016 -โ‚น10.3 Billion54.68%
2015 -โ‚น6.66 Billion309.5%
2014 -โ‚น1.63 Billion-29.88%
2013 -โ‚น2.32 Billion
2011 -โ‚น0.36 Billion-59.18%
2010 -โ‚น0.88 Billion-53.53%
2009 -โ‚น1.89 Billion-161.93%
2008 โ‚น3.04 B-187.43%
2007 -โ‚น3.49 Billion11.93%
2006 -โ‚น3.11 Billion31.69%
2005 -โ‚น2.37 Billion32.4%
2004 -โ‚น1.79 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚น48.01 Billion 1,056.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น5.88 Billion 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น14.34 B-445.57%๐Ÿ‡บ๐Ÿ‡ธ USA